Thermo Fisher Scientific vs Wacker Biotech: CDMO Comparison
Side-by-side comparison of Thermo Fisher Scientific and Wacker Biotech on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Thermo Fisher Scientific has more FDA inspections on record (5 vs 0) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Wacker Biotech has materially broader EMA GMP coverage (13 active certificates vs 1) — stronger EU footprint.
- Thermo Fisher Scientific maintains 9 MHRA / UK GMP certificates; Wacker Biotech does not.
On a 13-modality CDMO landscape, both Thermo Fisher Scientific and Wacker Biotech qualify as Plasmid DNA manufacturers; Thermo Fisher Scientific carries the higher composite Signal Score for Plasmid DNA programs in this comparison.
What to evaluate for Plasmid DNA programs
Both Thermo Fisher Scientific and Wacker Biotech qualify as Plasmid DNA CDMOs. When choosing between them for Plasmid DNA programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
GMP grade & purity
Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality.
Fermentation scale & yield
Match fermentation scale and yield to your vector or mRNA demand. Ask about high-yield strains and whether scale-up is validated.
Lead time
Plasmid is a common critical-path bottleneck. Evaluate realistic queue and turnaround against your program timeline.
Regulatory track record
Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.
Frequently asked: Thermo Fisher Scientific vs Wacker Biotech
Which has the stronger FDA inspection record, Thermo Fisher Scientific or Wacker Biotech?
Both Thermo Fisher Scientific and Wacker Biotech maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Thermo Fisher Scientific has 5 FDA inspections on record; Wacker Biotech has 0.
How do Thermo Fisher Scientific and Wacker Biotech compare on European GMP coverage?
Thermo Fisher Scientific holds 1 active EMA GMP certificate and 9 MHRA / UK certificates. Wacker Biotech holds 13 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — Thermo Fisher Scientific or Wacker Biotech?
Thermo Fisher Scientific is matched to 2 ClinicalTrials.gov records as a manufacturing partner; Wacker Biotech is matched to 0. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
Which is better for Plasmid DNA manufacturing — Thermo Fisher Scientific or Wacker Biotech?
Both Thermo Fisher Scientific and Wacker Biotech are tagged as Plasmid DNA CDMOs in our directory, so both are credible options for Plasmid DNA programs. The most important differentiator for Plasmid DNA selection is typically gmp grade & purity: Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Thermo Fisher Scientific carries a Signal Score of 83/100 and Wacker Biotech carries 82/100 — essentially tied for Thermo Fisher Scientific. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →